SIGNIFICANCE
An estimated 27 million surgical procedures are performed each year. Of these, 500,000 result in SSIs that comprise at least one third of all nosocomial infections, and are the most common nosocomial infection in surgical patients. These infections are responsible for 77% of the deaths in nosocomially infected surgical patients (Mangram et al., 1999) . Many studies show that SSIs increase length of hospital stay and costs. Patients who acquire an SSI double their length of hospital stay and risk of death (Dellinger, 2005) . Annual costs associated with increased hospitalization due to SSIs are in excess of $1.5 billion (Seal & Paul-Cheadle, 2004) . Despite many advances in infection control, SSIs remain a principal cause of morbidity and mortality (Mangram et al., 1999) .
According to the Centers for Disease Control and Prevention (CDC), endogenous skin bacteria (Staphylococcus aureus and coagulase-negative staphylococci) cause 34% of all SSIs. Studies show that the risk of SSIs is significantly increased if a surgical site is contaminated with a count of more than 10 5 micro-organisms per gram of tissue. Reduction in the number of these skin micro-organisms may decrease the risk of SSIs. One strategy to reduce the microbial colonization of skin is pre-operative skin preparation. The purpose of pre-operative skin preparation is to decrease resident and transient micro-organisms to subpathogenic levels quickly P re-operative skin preparation of the surgical site using appropriate anti-septic product is recognized by the Centers for Disease Control and Prevention Guideline for Prevention of Surgical Site Infection, 1999 , as a strongly recommended intervention to prevent surgical site infection. This article reviews anti-septic surgical skin preparation products according to the Food and Drug Administration classifications, efficacy, and safety. It also examines pertinent research regarding anti-septic products. This information provides the peri-operative registered nurse with information to make appropriate decisions when choosing anti-septic skin preparation products for surgical patients.
In the late 1860s, the concept of asepsis was introduced into the practice of surgery. The practice of asepsis has revolutionized surgery from a pursuit which frequently resulted in sepsis and death, to a medical intervention, which improves the quality and longevity of life. Despite the radical effect of aseptic technique on the practice of surgery, surgical site infections (SSIs) remain a significant preventable adverse outcome (Mangram, Horan, Pearson, Silver, & Jarvis, 1999) .
Sterilization of instruments, maintenance of a sterile field, anti-biotic prophylaxis, and hand disinfection have contributed to the reduction of SSIs. These practices combine to create an aseptic surgical environment. In the past, the focus of effectiveness of antiseptic products has been aimed at surgical hand scrubs with little attention being paid to patient skin preparation. The patient's own body, however, and to prevent the rebound of growth of microorganisms (AORN, 2006) . Pre-operative anti-septic skin preparation products are formulated to remove a broad spectrum of microbes quickly and to provide continuously a high level of anti-microbial action for up to 6 hr after use (Paulson, 2003) .
CLASSIFICATION OF HEALTHCARE ANTI-SEPTICS
In the past, many topical anti-microbials were marketed that may have been ineffective or unsafe. To ensure that products used by American consumers are safe and provide action as claimed by manufacturers, the Federal Drug Administration (FDA) Division of Over-the-Counter Drugs regulates anti-septic and other products. According to the FDA, preoperative skin preparation agents fall under the category of healthcare anti-septics and are defined as safe, rapid action, persistent products that act on a broad spectrum of microbes and significantly decrease the numbers of microbes on intact skin. These products must meet the testing specifications established in the FDA 1994 Tentative Final Monograph (TFM) for Healthcare Antiseptic Drug Products. The TFM establishes a framework for evaluation of safety and effectiveness of anti-septic healthcare products. Anti-septic healthcare products are classified into three categories: safe and effective and not misbranded (Category I); not safe and effective or misbranded (Category II); and safety and effectiveness cannot be confirmed because of lack of evidence (Category III). Anti-septic ingredients not listed in the TFM are considered new drugs, which require a New Drug Application before being marketed (Paulson, 2003) .
The FDA TFM has adopted methods proposed by the American Society for Testing and Materials to evaluate the efficacy of pre-operative skin anti-septics. Efficacy pertains to the ability of an anti-septic skin product to significantly reduce the number of resident and transient micro-organisms on the skin. It is expressed as a log reduction. The FDA requires a log 2 reduction on dry sites (i.e., abdomen) and log 3 reduction on moist sites (i.e., inguinal). The immediate action relates to how quickly the anti-septic agent reduces microbial levels. Persistence is the ability of an anti-microbial agent to prevent or inhibit microbial growth on the skin after the product use (Paulson, 2003) (Table 1) .
The selection of the most appropriate anti-septic product is the most essential step in pre-operative skin preparation. Although the efficacy, immediate action, and persistence of the product are crucial, they must be balanced with need to avoid tissue injury. The safety of pre-operative skin preparation anti-septics are a significant concern for the peri-operative registered nurse (RN). Many skin anti-septics contain ingredients that can cause a direct or indirect injury to the surgical patient. Direct injuries resulting from anti-septic agents include ophthalmic damage, ototoxicity, skin irritations, and anaphylactic reactions. Indirectly, injuries can occur when alcoholic skin preparations ignite, causing fire in the operating room. The RN should have a strong knowledge regarding the efficacy and characteristics of skin anti-septic agents for skin preparation of the surgical patient (Table 2) .
DESCRIPTION OF SKIN PREPARATION ANTI-SEPTIC AGENTS

Chlorhexidene Gluconate
Chlorhexidene gluconate (CHG) has immediate, persistent, and residual anti-microbial properties. This product has a strong tendency to bind the tissue, which contributes to its extended antimicrobial action. Depending on the concentration, it exerts bacteriostatic and bactericidal effects on a broad range of gram-positive and gram-negative bacteria. CHG has limited sporicidal activity (Paulson, 2003) .
Iodophor
Povidine-iodine (PVI) is the most commonly used form of iodophor and the most widely used pre-operative in the presence of blood, necrotic tissue, or purulence (Paulson, 2003) .
Parachlorometaxylenol
One of the oldest anti-microbials, parachlorometaxylenol (PCMX, also known as chloroxylenol) is relatively safe for human use. It has fair to good anti-microbial skin anti-septic. This product has an excellent immediate anti-microbial effect. PVI has good local tolerability: it is not irritating or painful to the skin. It is effective against gram-positive and gram-negative bacteria, fungi, and protozoa. With the appropriate length of exposure time and concentration, iodophors are also effective against mycobacterium, spores of Bacillus spp and Clostridium spp. PVI may be less effective efficacy. It is not widely used as a skin preparation agent because of its comparatively less effective anti-microbial action (Paulson, 2003) .
Alcohol and Alcohol-Based Agents
Alcohols are broad spectrum, fast-acting antimicrobials. They are ineffective against bacterial spores but generally effective against fungal species and some viruses. Although alcoholic anti-septics have excellent immediate anti-microbial action, they have limited persistence and residual effects (Paulson, 2003) . Currently, many products incorporate alcohol along with other anti-septic agents to address the lack of persistence of alcohol. The addition of other antiseptic agents such as iodophor or CHG to an alcoholbased agent is necessary to extend its persistence. Another strategy to improve persistence of alcohol is to add a preservative such as zinc pyrithione (ZPT). The addition of ZPT provides persistence to alcohol that is absent if it is used alone. This combination of alcohol and ZPT demonstrates rapid reduction of resident and transient flora, which exceeds FDA requirements (Seal & Paul-Cheadle, 2004) .
The combination of alcohol with CHG shows an improvement in immediate anti-microbial properties that provide superior clinical efficacy as a skin antiseptic agent. The CHG component of this combination results in persistent anti-microbial action (Paulson, 2003) .
Another anti-septic agent, which may benefit from the addition of alcohol, is iodophor. The combination of isopropyl alcohol and iodophor results in a product with immediate efficacy that requires less time for application in comparison with typical iodophor agents (Segal & Anderson, 2002) .
REVIEW OF PRE-OPERATIVE SKIN DISINFECTION RESEARCH
A number of studies have examined the most effective skin anti-septic agent for infection prevention in central venous pressure (CVP) catheters. A metaanalysis of vascular catheter site studies found CHG to be more effective in preventing catheter-related bloodstream infections than povidine-iodine (Chaiyakunapruk et al., 2002) . On the basis of these studies, the CDC has published guidelines specifically recommending 2% CHG as a skin preparation agent before insertion of CVP catheters (CDC, 2002) . Unfortunately, there is no definitive guideline for pre-operative skin anti-septic agents.
Although PVI is categorized by the FDA as a Category I (safe and effective) skin anti-septic, studies have demonstrated greater immediate and persistent anti-microbial action by other anti-septic agents. One study demonstrated that the addition of alcohol to PVI results in a more efficacious anti-septic agent. Segal and Anderson (2002) found that SSI rate was lower in cardiac surgical patients who had skin preparation with an iodophor/alcohol product versus PVI. The authors note that the combination of iodophor and alcohol in a water-insoluble film provides anti-microbial effects for up to 12 hr after application and provide a bacteriostatic action under a dressing for up to 3 days. Hibbard (2005) conducted clinical trials to determine the best pre-operative skin preparation agent on the basis of three criteria: immediate, persistent, and cumulative action. He found that the combination of CHG and alcohol was superior in all three criteria in comparison with four other anti-septics: 70% alcohol, 2% CHG, and 4% CHG or PVI.
Ostrander, Botte, and Brage (2005) compared the combination of CHG and alcohol, PVI and alcohol, and chloroxylenol alone on pre-operative skin disinfection of the foot and ankle. They found that the combination of CHG and alcohol was the most effective agent for eliminating bacteria from the foot. Guthery, Seal, and Anderson (2005) compared a skin anti-septic formulation of ZPT/alcohol with iodine/CHG. They concluded that this product exceeded the efficacy of both CHG and iodine. Seal and Paul-Cheadle (2004) tested ZPT with alcohol in a "systems approach" to pre-operative skin preparation, which included washing of the sites at 12 and 6 hr before the pre-operative skin preparation using either the ZPT with alcohol product or 10% PVI. The alcohol-based product demonstrated greater antimicrobial efficacy than the iodine-based product at nearly every test point and continued beyond the wound closure.
There are few studies that assess the effect of preoperative skin disinfection on SSI rates. However, logic dictates that eliminating the microbes, which are implicated in most SSIs, will decrease infection rates. The anti-septic products with the broad spectrum, immediate, and persistent anti-microbial properties should be the product of choice for the pre-operative preparation of skin. As this review indicates, products that combine alcohol with CHG, PVI, or ZPT may be the most effective skin disinfectants. In products without any alcohol, CHG alone is the more effective and persistent skin anti-septic than PVI.
CONCLUSIONS
SSIs are a significant issue for healthcare providers. According to the CDC (Mangram et al., 1999) , techniques aimed at reduction of microbial contamination of the patient's tissue are an important prevention measure for SSIs. Effective pre-operative skin disinfection provides an opportunity to reduce SSIs. Anti-septic agents for skin disinfection must be selected on the basis of efficacy and safety. This requires that peri-operative RNs have thorough knowledge of product characteristics and manufacturer's instructions for each anti-septic product. The informed RN is able to choose among the available anti-septics for the most appropriate skin disinfection product to protect each patient from SSI.
